ATC codes:
L01CA04
EMLc
Indication
Rhabdomyosarcoma primary site
ICD11 code:
2C25.Z
INN
Vinorelbine
Medicine type
Chemical agent
List type
Complementary
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
10 mg per mL in 1 mL vial ;
10 mg per mL in 5 mL vial
Oral > Solid: 20 mg ; 30 mg ; 80 mg (EML)
Oral > Solid: 20 mg ; 30 mg ; 80 mg (EML)
Sex
All
Age
Also recommended for children
Therapeutic alternatives
The recommendation is for this specific medicine
Patent information
Patents have expired in most jurisdictions
Read more
about patents.
Summary of evidence and Expert Committee recommendations
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended deletion of vinorelbine 80 mg capsules from the EMLc, and modification of the description of the parenteral forms on the EML and EMLc to 10 mg/mL in 1 mL and 5 mL vials.